Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL354P is classified as a processed pseudogene derived from 7SL RNA, which is a component of the signal recognition particle (SRP) responsible for directing proteins to cellular membranes. Unlike active 7SL RNA genes, most 7SL-related sequences in the human genome are pseudogenes – remnants of reverse transcription events that reinsert RNA-derived DNA into the genome but lack biological function and are not expressed. RN7SL354P does not encode functional RNA and has no established protein product, receptor activity, or therapeutic relevance. Pseudogenes occasionally play regulatory roles for related genes, but there is no evidence RN7SL354P is involved in such processes. It is generally considered a genomic artifact rather than an actionable drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 354, pseudogene (RN7SL354P).